TANDEM DIABETES CARE INC's ticker is TNDM and the CUSIP is 875372203. A total of 299 filers reported holding TANDEM DIABETES CARE INC in Q4 2022. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $886 | +8.2% | 42,643 | +27.8% | 0.04% | +16.7% |
Q2 2023 | $819 | -78.2% | 33,373 | -64.0% | 0.04% | -79.8% |
Q1 2023 | $3,762 | +28.3% | 92,626 | +42.0% | 0.18% | +9.9% |
Q4 2022 | $2,933 | -99.9% | 65,246 | +6.6% | 0.16% | -8.5% |
Q3 2022 | $2,928,000 | -16.2% | 61,181 | +3.7% | 0.18% | -32.7% |
Q2 2022 | $3,492,000 | -37.1% | 58,992 | +23.6% | 0.26% | -27.5% |
Q1 2022 | $5,551,000 | +7.5% | 47,731 | +39.1% | 0.36% | -43.7% |
Q4 2021 | $5,166,000 | +18.8% | 34,319 | -5.8% | 0.64% | +11.4% |
Q3 2021 | $4,348,000 | +31.0% | 36,418 | +6.9% | 0.58% | -48.2% |
Q2 2021 | $3,319,000 | +164.7% | 34,080 | +139.8% | 1.12% | +178.6% |
Q1 2021 | $1,254,000 | -23.7% | 14,214 | -17.3% | 0.40% | -14.5% |
Q4 2020 | $1,644,000 | -15.8% | 17,183 | -0.1% | 0.47% | -24.4% |
Q3 2020 | $1,953,000 | +20.6% | 17,203 | +5.1% | 0.62% | +12.7% |
Q2 2020 | $1,619,000 | +456.4% | 16,363 | +261.8% | 0.55% | +347.2% |
Q1 2020 | $291,000 | – | 4,523 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Octagon Capital Advisors LP | 474,929 | $22,725,000 | 3.92% |
Soleus Capital Management, L.P. | 415,200 | $19,867,000 | 2.70% |
First Light Asset Management, LLC | 485,620 | $23,237,000 | 2.35% |
Eagle Health Investments LP | 196,400 | $9,398,000 | 2.16% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 218,049 | $10,434,000 | 1.66% |
EMINENCE CAPITAL, LP | 1,590,787 | $76,119,000 | 1.59% |
Brown Capital Management | 2,010,230 | $96,190,000 | 1.35% |
Chicago Capital, LLC | 479,873 | $22,962,000 | 1.33% |
Intrinsic Edge Capital Management LLC | 247,391 | $11,838,000 | 1.29% |
Bellevue Group AG | 1,566,015 | $74,933,000 | 1.08% |